comparemela.com

Latest Breaking News On - Regulatory news - Page 6 : comparemela.com

Clariane: Information relating to the availability of a prospectus approved by the Autorité des marchés financiers under number 24-191

Regulatory News: NOT FOR DISTRIBUTION IN THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA OR JAPAN. THIS COMMUNICATION IS NOT AN OFFER OF SECURITIES FOR SALE IN THE UNITED STATES OF AMERICA OR ANY

Champagne ardenneFrance generalUnited kingdomUnited statesFlorian bacheletLeima valeursJulie maryNeither the companyAker holdingEuropean parliamentGp recovery fundFooted seriesFinancial servicesHolding malakoff humanisRegulatory newsReserved capital increase

Katoro Gold : FY2023 Annual Report Final 30 05 2024 Katoro Signed

KATORO GOLD PLC ANNUAL REPORT AND FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023 .

United kingdomDar es salaamSouth africaLake victoriaTanzania generalCity ofPeter squareBen harberLouis coetzeeLudgate hillLukas mareeLouis scheepersSean wadeKatoro gold plcLondon stock exchange regulatory news serviceBarclays bank plc

UBS Group AG: UBS completes merger of UBS AG and Credit Suisse AG

Regulatory News: Ad hoc announcement pursuant to Article 53 LR. UBS Group AG (NYSE:UBS) (SWX:UBSN) announces today that it has completed the merger of UBS AG and Credit Suisse AG. The completion

United kingdomSergiop ermottiCredit suisseUbs agGroup ag annualRegulatory newsCommercial registerChief executive officer sergioRisk factorsIhr portfolio

MEMSCAP - Minutes of the Annual Ordinary Shareholders Meeting of May 31, 2024

MEMSCAP - Minutes of the Annual Ordinary Shareholders Meeting of May 31, 2024
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Regulatory newsEuronext parisMicro electro mechanical systemsParc activillage des fontaines

Sensorion Publishes Results of Combined Shareholders General Meeting Resolutions

Regulatory News: Sensorion a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss.

Institut pasteurRegulatory newsCombined general meetingGeneral meetingCisplatin induced ototoxicityCochlear limitedSudden sensorineural hearing loss

vimarsana © 2020. All Rights Reserved.